Does ARIPIPRAZOLE LAUROXIL Cause Psychomotor hyperactivity? 8 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Psychomotor hyperactivity have been filed in association with ARIPIPRAZOLE LAUROXIL (ARISTADA). This represents 0.2% of all adverse event reports for ARIPIPRAZOLE LAUROXIL.
8
Reports of Psychomotor hyperactivity with ARIPIPRAZOLE LAUROXIL
0.2%
of all ARIPIPRAZOLE LAUROXIL reports
0
Deaths
2
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From ARIPIPRAZOLE LAUROXIL?
Of the 8 reports, 2 (25.0%) required hospitalization.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ARIPIPRAZOLE LAUROXIL. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does ARIPIPRAZOLE LAUROXIL Cause?
Off label use (1,024)
Needle issue (567)
Injection site pain (426)
Drug ineffective (262)
Weight increased (207)
Product administered at inappropriate site (198)
Hallucination, auditory (172)
Therapeutic response shortened (172)
Underdose (169)
Incorrect dose administered (162)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which ARIPIPRAZOLE LAUROXIL Alternatives Have Lower Psychomotor hyperactivity Risk?
ARIPIPRAZOLE LAUROXIL vs ARIXTRA
ARIPIPRAZOLE LAUROXIL vs ARMODAFINIL
ARIPIPRAZOLE LAUROXIL vs AROMASIN
ARIPIPRAZOLE LAUROXIL vs ARSENIC TRIOXIDE
ARIPIPRAZOLE LAUROXIL vs ARTEMETHER\LUMEFANTRINE